Black Hawk Acquisition Corporation Class A Ordinary Shares
BKHABlack Hawk Acquisition Corporation Class A Ordinary Shares (BKHA) is a blank check company formed to identify and acquire a target business in the technology, media, or telecommunications sectors. Established as a special purpose acquisition company (SPAC), it aims to facilitate mergers or acquisitions that align with its strategic focus, providing investors with an opportunity to participate in potential growth through its operational and financial expertise.
Company News
Vesicor Therapeutics, a biotech company developing p53-based cancer therapeutics, announced the appointment of Michael Tolentino, M.D. as Chief Executive Officer effective March 17, 2026. Tolentino, a serial entrepreneur with over 20 years of biotech experience, succeeds founder Luo Feng who transitions to Chief Scientific Officer. The leadership...
Vesicor Therapeutics, a biotechnology company focused on p53-based cancer therapeutics, has entered into a business combination agreement with Black Hawk Acquisition Corporation to create a public company advancing its drug candidate.
